<turbo-stream action="append" target="news"><template>  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Dare-Bioscience-Inc-US23666P1012">Dare Bioscience, Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">GlobeNewsWire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">vor 4 Monaten</div>
        <span class="me-2 new badge text-secondary bg-gray-200" data-bs-toggle="tooltip"
              data-bs-title="Automatisch aus dem Englischen übersetzt. Standardsprache in den Einstellungen ändern."
              title="Automatisch aus dem Englischen übersetzt. Standardsprache in den Einstellungen ändern.">EN</span>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.globenewswire.com/news-release/2026/07/20/3329781/30757/en/dar%c3%a9-bioscience-launches-nationwide-virtual-bus-tour-webinar-series-to-showcase-commercial-strategy-and-growth-opportunities.html">Daré Bioscience startet landesweite virtuelle Bus-Tour-Webinarreihe zur Präsentation der kommerziellen Strategie und Wachstumschancen</a>
    </div>

      <div class="me-0 me-md-5">
        SAN DIEGO, 20. Juli 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), ein zweckorientiertes Biotech-Unternehmen im Gesundheitsbereich, das sich ausschließlich darauf konzentriert, die Lücke in der Frauengesundheit zwischen vielversprechender Wissenschaft und realen Lösungen zu schließen, gab heute den Start seiner „Across the U.S.“ Virtual Bus Tour Webinar Series bekannt, einer meh...
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Dare-Bioscience-Inc-US23666P1012">Dare Bioscience, Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">GlobeNewsWire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">vor 4 Monaten</div>
        <span class="me-2 new badge text-secondary bg-gray-200" data-bs-toggle="tooltip"
              data-bs-title="Automatisch aus dem Englischen übersetzt. Standardsprache in den Einstellungen ändern."
              title="Automatisch aus dem Englischen übersetzt. Standardsprache in den Einstellungen ändern.">EN</span>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.globenewswire.com/news-release/2026/07/09/3324804/30757/en/Dar%C3%A9-Bioscience-CEO-Sabrina-Martucci-Johnson-to-Participate-in-Virtual-Investor-Closing-Bell-Event.html">Daré Bioscience-CEO Sabrina Martucci Johnson nimmt an virtuellem Investor Closing Bell Event teil</a>
    </div>

      <div class="me-0 me-md-5">
        Live-Video-Webcast am Dienstag, 14. Juli, um 16:00 Uhr ET Hier registrieren
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Dare-Bioscience-Inc-US23666P1012">Dare Bioscience, Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">GlobeNewsWire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">vor 4 Monaten</div>
        <span class="me-2 new badge text-secondary bg-gray-200" data-bs-toggle="tooltip"
              data-bs-title="Automatisch aus dem Englischen übersetzt. Standardsprache in den Einstellungen ändern."
              title="Automatisch aus dem Englischen übersetzt. Standardsprache in den Einstellungen ändern.">EN</span>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.globenewswire.com/news-release/2026/07/01/3320620/30757/en/Dar%C3%A9-Bioscience-Announces-Flora-Sync-LF5-Is-Now-Available-Through-Its-Direct-to-Consumer-Platform.html">Daré Bioscience: Flora Sync LF5™ jetzt über Direct-to-Consumer-Plattform verfügbar</a>
    </div>

      <div class="me-0 me-md-5">
        Kommerzieller Start beginnt Erstes Verbrauchereinnahmequelle des Unternehmens, bringt wissenschaftlich gestützte Gesundheitslösungen für Frauen direkt zu den Verbrauchern Kommerzieller Start beginnt Erstes Verbrauchereinnahmequelle des Unternehmens, bringt wissenschaftlich gestützte Gesundheitslösungen für Frauen direkt zu den Verbrauchern
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Dare-Bioscience-Inc-US23666P1012">Dare Bioscience, Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">GlobeNewsWire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">vor 4 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.globenewswire.com/news-release/2026/06/25/3317617/30757/en/Dar%C3%A9-Bioscience-Highlights-Revenue-Opportunity-as-CEO-Discusses-Upcoming-Launch-of-Flora-Sync-LF5-in-Virtual-Investor-What-This-Means-Segment.html">Daré Bioscience Highlights Revenue Opportunity as CEO Discusses Upcoming Launch of Flora Sync LF5™ in Virtual Investor “What This Means” Segment</a>
    </div>

      <div class="me-0 me-md-5">
        First consumer health product positions Daré for revenue generation while expanding its women&#39;s health leadership platform
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Dare-Bioscience-Inc-US23666P1012">Dare Bioscience, Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">GlobeNewsWire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">vor 5 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.globenewswire.com/news-release/2026/06/18/3314270/30757/en/Dar%C3%A9-Bioscience-to-Showcase-Leadership-in-Women-s-Health-Innovation-at-BIO-International-Convention-2026.html">Daré Bioscience to Showcase Leadership in Women&#39;s Health Innovation at BIO International Convention 2026</a>
    </div>

      <div class="me-0 me-md-5">
        President and CEO, Sabrina Martucci Johnson, to participate in featured industry panels and present Company&#39;s vision for transforming women&#39;s health President and CEO, Sabrina Martucci Johnson, to participate in featured industry panels and present Company&#39;s vision for transforming women&#39;s health
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Dare-Bioscience-Inc-US23666P1012">Dare Bioscience, Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">GlobeNewsWire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">vor 5 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.globenewswire.com/news-release/2026/05/26/3301028/30757/en/dar%c3%a9-bioscience-receives-nih-funding-award-notice-to-advance-dare-hpv-its-novel-investigational-treatment-for-persistent-high-risk-hpv-infection-the-most-common-cause-of-cervical-c.html">Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-HPV, its Novel Investigational Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer</a>
    </div>

      <div class="me-0 me-md-5">
        Receipt of award notice for second $1.0 million tranche of NIAID funding brings total NIH funding award for DARE-HPV to $2.0 million Funding award milestone follows Daré&#39;s announcement last week of the initiation of its Phase 2 clinical study of DARE-HPV — representing the first time women with persistent high-risk HPV infection may have access to this pharmacologic treatment as part of a clini...
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Dare-Bioscience-Inc-US23666P1012">Dare Bioscience, Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">GlobeNewsWire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">vor 6 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.globenewswire.com/news-release/2026/05/18/3296547/30757/en/Dar%C3%A9-Bioscience-Initiates-Phase-2-Study-of-DARE-HPV-a-Novel-Pharmacologic-Treatment-for-Persistent-High-Risk-HPV-Infection-with-No-FDA-Approved-Therapies.html">Daré Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-Approved Therapies</a>
    </div>

      <div class="me-0 me-md-5">
        Each year, an estimated six million women in the United States acquire a high-risk HPV infection — and there are no FDA-approved treatments DARE-HPV development is backed by a $10 million U.S. government (ARPA-H)-funded contract; topline data readout expected in 2027 SAN DIEGO, May 18, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely ...
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-secondary bg-gray-200">
          Neutral
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Dare-Bioscience-Inc-US23666P1012">Dare Bioscience, Inc.</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">GlobeNewsWire</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">vor 6 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.globenewswire.com/news-release/2026/05/14/3295307/30757/en/Dar%C3%A9-Bioscience-Reports-First-Quarter-2026-Financial-Results-and-Provides-Business-Update.html">Daré Bioscience Reports First Quarter 2026 Financial Results and Provides Business Update</a>
    </div>

      <div class="me-0 me-md-5">
        Company Highlights Second Positive DSMB Review of Interim Data from Ovaprene® Phase 3 Clinical Trial, DARE to PLAY™ Anticipated Dispensing Commencement and Flora Sync LF5™ Commercial Launch Summer 2026; First Product Revenue Expected in June 2026; Call Hosted During National Women&#39;s Health Week.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

</template></turbo-stream><turbo-stream action="replace" target="link"><template><div id="link">
    <a class="btn btn-outline-primary btn--small" data-turbo-stream="" href="/news/Dare-Bioscience-Inc-US23666P1012/load_more?page=4">
      Mehr Neuigkeiten anzeigen
      <i class="fa fa-arrow-down fa-fw"></i>
</a></div>
</template></turbo-stream>